NTRP compared with KYNB: revenue, margins and what each company keeps, and the suppliers and customers both name

NTRPNextTrip, Inc.

Mkt capRevenueRevenue

KYNBKyntra Bio, Inc.

Mkt capRevenueRevenue

Compare

NTRPNextTrip, Inc.

KYNBKyntra Bio, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

NTRPNextTrip, Inc.

1.16▲+7.61%· post 1.17

Mkt cap$17.6MRevenue$546,687Q2 FY27Revenue$4MFY26

KYNBKyntra Bio, Inc.

4.43▼−0.60%· post 4.32

ClosedNov 3 '26

Mkt cap$17.5MRevenue$4MQ1 FY26Revenue$6MFY25

Compare

ClosedNov 3 '26

NTRPNextTrip, Inc.

KYNBKyntra Bio, Inc.

1.16▲+7.61%post 1.17

Price

4.43▼−0.60%post 4.32

$17.6M

Mkt cap

$17.5M

Q2 FY27$546,687

Revenue

$4MQ1 FY26

FY26$4M

Revenue

$6MFY25

NTRP1.16▲+7.61%vsKYNB4.43▼−0.60%ClosedNov 3 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

NTRP: latest quarter is a loss; flow not drawable. KYNB: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NTRP 0

None

Shared 0

No disclosed counterparties: NTRP.

Only KYNB 10

AZNAstraZeneca AB ("AstraZeneca")customer

—Astellas Pharma Inc. ("Astellas")unlistedsupplier

—Fortis Therapeutics, Inc. ("Fortis")unlistedsupplier

—Shanghai SynTheAll Pharmaceutical Co., Ltd. ("WuXi STA")unlistedsupplier

6 more · KYNB chain ›

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

NTRP, solidKYNB, dashed